🇺🇸 FDA
Patent

US 11505782

Cell-based vehicles for potentiation of viral therapy

granted A61KA61K35/13A61K35/28

Quick answer

US patent 11505782 (Cell-based vehicles for potentiation of viral therapy) held by Calidi Biotherapeutics, Inc. expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Calidi Biotherapeutics, Inc.
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
63
CPC classes
A61K, A61K35/13, A61K35/28, A61K35/768, A61K40/10